Viewing Study NCT06283550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-03-13 @ 4:25 AM
Study NCT ID: NCT06283550
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-17
First Post: 2024-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy
Sponsor: Innovaderm Research Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Hand Eczema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None abrocitinib View
None corticosteroid therapy View
None eczema View
None atopic dermatitis View